Molecule Name |
DB09309
|
DrugBank Groups |
Experimental
|
Cluster No |
2822
|
Smiles |
O=C1(OC(CC=CC=CC(O)C(CC(C(C(C(C1)O)OC)OC3(OC(C(OC2(OC(C(OC(=O)CC(C)C)C(C2)(O)C)C))C(C3O)N(C)C)C))CC=O)C)C)
|
Download |
mol2, pdbqt
|
TPSA |
602,31
|
Non-H Atoms |
55
|
Non-C/H Atoms |
15
|
Metal-Atoms |
0
|
Electronegative Atoms |
15
|
Stereo Centers |
16
|
Rotatable Bonds |
12
|
Rings Closures |
3
|
Small Rings |
2
|
Aromatic Rings |
0
|
Aromatic Atoms |
0
|
sp3-Atoms |
45
|
Symmetric atoms |
2
|
cLogS |
-4,357
|
MW |
785,965
|
cLogP |
2,5739
|
HBA |
15
|
HBD |
4
|
Ro5 violations |
2
|
Druglikeness |
1,384
|
DrugScore |
0,221080170618868
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
high
|
Blood-Brain Barrier |
BBB-
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-2,35
|
Caco-2 Permeability 2 |
0,4768
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,3582
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,6783
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
IV
|
Rat Acute Toxicity (LD50, mol/kg) |
1,8513
|
Carcinogenicity (Three-class) |
Non-required
|